Strange C - Search Results

1

Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.

Argula RG, Karwa A, Lauer A, Gregg D, Silver RM, Feghali-Bostwick C, Schanpp LM, Egbert K, Usher BW, Ramakrishnan V, Hassoun PM, Strange C. Argula RG, et al. Among authors: strange c. Ann Am Thorac Soc. 2017 May;14(5):682-689. doi: 10.1513/AnnalsATS.201608-655OC. Ann Am Thorac Soc. 2017. PMID: 28282243 Free PMC article.

2

Growth and characterization of fibroblasts obtained from bronchoalveolar lavage of patients with scleroderma.

Ludwicka A, Trojanowska M, Smith EA, Baumann M, Strange C, Korn JH, Smith T, Leroy EC, Silver RM. Ludwicka A, et al. Among authors: strange c. J Rheumatol. 1992 Nov;19(11):1716-23. J Rheumatol. 1992. PMID: 1491389

3

Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor.

Ohba T, McDonald JK, Silver RM, Strange C, LeRoy EC, Ludwicka A. Ohba T, et al. Among authors: strange c. Am J Respir Cell Mol Biol. 1994 Apr;10(4):405-12. doi: 10.1165/ajrcmb.10.4.7510986. Am J Respir Cell Mol Biol. 1994. PMID: 7510986

4

Failure of the circulatory system limits exercise performance in patients with systemic sclerosis.

Sudduth CD, Strange C, Cook WR, Miller KS, Baumann M, Collop NA, Silver RM. Sudduth CD, et al. Among authors: strange c. Am J Med. 1993 Oct;95(4):413-8. doi: 10.1016/0002-9343(93)90311-c. Am J Med. 1993. PMID: 8213874

5

Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease.

Silver RM, Warrick JH, Kinsella MB, Staudt LS, Baumann MH, Strange C. Silver RM, et al. Among authors: strange c. J Rheumatol. 1993 May;20(5):838-44. J Rheumatol. 1993. PMID: 8336309 Clinical Trial.

6

Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma.

Ludwicka A, Ohba T, Trojanowska M, Yamakage A, Strange C, Smith EA, Leroy EC, Sutherland S, Silver RM. Ludwicka A, et al. Among authors: strange c. J Rheumatol. 1995 Oct;22(10):1876-83. J Rheumatol. 1995. PMID: 8991985

7

Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis.

Bolster MB, Ludwicka A, Sutherland SE, Strange C, Silver RM. Bolster MB, et al. Among authors: strange c. Arthritis Rheum. 1997 Apr;40(4):743-51. doi: 10.1002/art.1780400422. Arthritis Rheum. 1997. PMID: 9125259

8

Hemodynamic effects of epoprostenol in patients with systemic sclerosis and pulmonary hypertension.

Strange C, Bolster M, Mazur J, Taylor M, Gossage JR, Silver R. Strange C, et al. Chest. 2000 Oct;118(4):1077-82. doi: 10.1378/chest.118.4.1077. Chest. 2000. PMID: 11035680

9

Pulmonary hypertension in interstitial lung disease.

Strange C, Highland KB. Strange C, et al. Curr Opin Pulm Med. 2005 Sep;11(5):452-5. doi: 10.1097/01.mcp.0000174250.38188.6d. Curr Opin Pulm Med. 2005. PMID: 16093821 Review.

10

Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease.

Strange C, Bolster MB, Roth MD, Silver RM, Theodore A, Goldin J, Clements P, Chung J, Elashoff RM, Suh R, Smith EA, Furst DE, Tashkin DP; Scleroderma Lung Study Research Group. Strange C, et al. Am J Respir Crit Care Med. 2008 Jan 1;177(1):91-8. doi: 10.1164/rccm.200705-655OC. Epub 2007 Sep 27. Am J Respir Crit Care Med. 2008. PMID: 17901414 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

331 results

Search Page

Filters